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Gender and Race Differences in Juvenile Mental Health Symptoms: MAYSI-2 National Norm Study
Gina Vincent, PhD, Thomas Grisso, PhD, Anna Terry, BA, & Steve Banks, PhD, University of Massachusetts Medical School, Supported by William T. Grant Foundation, (PI: Grisso), Law and Psychiatry Program
Research Questions
1.	 Are there differences between gender and racial/ethnic groups in the    
	 reporting	of	clinically	significant	levels	of	mental	health	symptoms	on	the			
 MAYSI-2 nationwide?
2. Where differences exist, were these differences consistent        
	 (homogenous)	across	all	JJ	sites	and	across	demographic	subgroups?
    Sample Characteristics
N=70,423 from 283 facilities in 19 states
u	Gender:   Boys - 78% Girls - 22%
u	Age	(years):         12-14 - 29% 15-17 -71%
u	Ethnicity/Race:   Black - 33%     Hispanic - 24%    White - 39%  Other ->2%      
u Gate:	     Probation - 36% Pretrial Detention - 42% Corrections - 22%
u	Density:  Urban - 78% Rural - 22% 
u	Region:   West - 17%   Midwest - 44% South - 17% Northeast - 22%
u	Time	of	MAYSI-2	Administration	(hrs	after	intake): 
   First few hours - 56%    6 to 24 hrs - 32%     =/> 48 hrs - 12% 
Meta-analytic Procedures
u	Unit of Analysis – Site	(JJ	Facility)
u	Separate Analyses for Each MAYSI-2 Clinical Scale  
– TRAUMATIC EXPERIENCES not included
u	Examined	Odds	of	Scoring	>	Caution	Cut-offs
	 	 	 	 	 –Past	research	was	done	to	determine	clinically	significant		 	
	 	 	 	 	 levels	of	disturbance.
u	Variables for Testing Interactions/Controls
     • Gender 
	 	 	 	 	 •	 Age	Group	(12-14,	15-17)	
	 	 	 	 	 •	 Race	(Black,	Hispanic,White)
	 	 	 	 	 •	 Legal	Status	(pre	vs.	post-adjudication)
	 	 	 	 	 •	 Time	of	MAYSI-2	Administration
Gender Effect Averaged Across Sites
u	Large Effects:
  •	 Suicide	Ideation		 	 	 OR	=	2.4
u	Medium Effects:
  •	 Angry-Irritable		 	 	 OR	=	1.8
  •	 Depressed-Anxious			 OR	=	1.95	–	2.14
  •	 Somatic	Complaints		 OR	=	1.8
u	No Effect:
  •	 Alcohol-Drug	Problems	–	OR	=	1.04,	but	interacts	with	age:
    –	 12-14	year	olds	–	girls	>	boys	(OR=1.6)
    – 15-17 year olds – no gender difference
Cochran-Mantel-Haenszel (CMH) 
Calculated Odds Ratios
ORs weighted for 
reliability 
General Linear Modeling
Produce Avg OR across all sites for each effect (Gender, etc) 
I2  - Test Homogeneity of  ORs
If  Yes
Consistent Effect 
If  No 
Explain w/interactions?
Meta-analytic Procedures
Conclusions
There is wide variability in racial differences 
across sites
u	White	youths	were	most	likely	to	report	problem	levels	of	alcohol		
	 or	drug	use,	but	the	disparity	varied	widely	across	gates	and	states
 
u	Race	effects	were	non-existent	or	small	on	all	other	MAYSI-2			 	
 scales 
Implication:
 u	Most	race-related	differences	in	JJ	were	small	and	in	the	same		
 general direction as national reports of differences in the     
	 community.
u	The	alcohol-drug	race	differences	in	JJ	may	be	due	to	“real”	
	 community	differences,	rather	than	a	difference	produced	by	racial	
	 discrimination	in	detention	decisions	
Aggregate-level Gender Differences
(% Above “Clinical” Cut Off)
Girls
Boys
Alc/Drugs Anger Dep-Anx Somatic Suicide Thought
Conclusions
Girls in JJ were much more likely than boys to report 
clinically significant levels of  symptoms
u	Higher	rates	of	symptoms	in	girls	than	boys	in	JJ	are	not	site	specific		 	
	 findings	–	generalizes	across	the	U.S.
u	Even	for	alcohol-drug	use,	at	least	for	younger	youths
Implication:
u	Girls	who	enter	the	JJ	system	may	represent	a	more	disturbed	or	difficult		
	 subpopulation	of	girls.	
u	Clinicians	should	anticipate	“age-inappropriate”	increased	risk	of		 	 	
	 substance	use	among	younger	girls
Race effect averaged across sites
u	Some are and Some are Not.  
	 Whites,	on	average,	were	more	likely	to	report	clinically		 	 	
	 significant	levels	of	symptoms	than	Blacks	or	Hispanics
u	Medium to Large Effects
 • Alcohol Drug Scale  
  –	 Whites	>	Blacks	 			 	 OR	=	2.3		Large	ES
  –	 Hispanics	>	Blacks						 OR	=	1.7		Medium	ES
u	Small Effects
 • Suicide	Ideation	(SI)		 	 W	v.	B	=	1.45;	W	v.	H	=	1.16
 • Somatic	Complaints	(SC)			W	v.	B	=	1.46;	W	v.	H	=	1.26
When Do Racial Differences Vary 
Across Youths?
u Findings on the Alcohol-Drug scale and scales other than    
 SI and SC were not consistent across sites
u	Potential	moderators	in	the	variability	in	the	magnitude	of	the			
	 odds	ratios	between	Whites	&	Blacks:
  • Age		(larger	for	older	youths)
  • Gate	(larger	for	pre-adjudicated	youths)
  • State
Aggregate-level Race Differences 
(% Above “Clinical” Cut-Off)
Black Hispanic White
Alcohol Drug Angry Irritable
Depressed Anxious Somatic
Suicide Ideation Though Disorder (boys)
